Thermo Fisher Scientific and Arsenal Biosciences Collaborate to Support Clinical Manufacturing of Autologous T-Cell Therapies
Thermo Fisher Scientific, the world leader in serving science, and Arsenal Biosciences, Inc. (ArsenalBio), a clinical-stage cell therapy company engineering advanced chimeric antigen receptor (CAR)-T cell therapies for solid tumors, today announced an update to our strategic collaboration to further the development of manufacturing processes for new cancer treatments. This research and process development-focused collaboration has enabled ArsenalBio to develop a robust manufacturing process for their next-generation, programmable autologous T cells for the treatment of cancer.
ArsenalBio recently advanced its lead product candidate into clinical manufacturing of its autologous integrated circuit T cell (ICT) therapy for platinum-resistant ovarian cancer. ArsenalBio’s work to develop multi-functional CAR-T cell therapies is enabled by Thermo Fisher’s Cell Therapy Systems (CTS) portfolio of products, including the Gibco™ CTS™ Xenon™ Electroporation System and the Gibco™ CTS™ Rotea™ Counterflow Centrifugation System.
“Our programmable cell therapy technology holds the potential to help patients with aggressive and complex cancers who currently have few treatment options,” said Ken Drazan, M.D., co-founder and chief executive officer, ArsenalBio. “To bring the promise of this technology to patients we’ll need to execute at speed and scale as we transition to clinical development. Our relationship with Thermo Fisher allows us to combine their fit-for-purpose solutions and internal expertise with our team’s innovative approach to clinical research and process development capabilities to manufacture ArsenalBio’s products and explore future therapeutic innovation.”
Thermo Fisher began its collaboration with ArsenalBio in 2020 to help ArsenalBio overcome challenges associated with cell therapy manufacturing by working together to support development of a clinical-scale gene editing process. In addition, ArsenalBio received early access to Thermo Fisher’s latest instrumentation and reagents.
“By collaborating with ArsenalBio as they pioneer a new approach to treat solid tumors using engineered T cell therapies, we’re helping bring more options to those who are most in need of innovative treatments,” said Betty Woo, vice president of cell, gene and advanced therapies, Thermo Fisher. “Through our Cell Therapy Collaboration Program, we are enabling the industry shift from reactive to proactive, applying our biological and technical expertise to improve the economics of therapy production, and moving toward expanded access to patients worldwide.”
Thermo Fisher’s CTS portfolio of products are cGMP manufactured, designed to meet applicable cell therapy standards, and include traceability and regulatory documentation to help customers transition from research to clinical production.
For more information about Thermo Fisher’s cell therapy collaboration partnership program, please visit thermofisher.com/collabcenterpartnership.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230329005043/en/
Contact information
Media:
Kristin Blake
Thermo Fisher Scientific
Phone: 760-637-1166
Email: kristin.blake@thermofisher.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Games of the Future 2025 Set to Bring the World Together in UAE for the Next Generation of Sport24.10.2025 12:34:00 EEST | Press release
Abu Dhabi, UAE will host the Games of the Future 2025 (GOTF 2025), the groundbreaking global event where phygital sports bring together elite clubs, athletes, and gamers to compete in cutting-edge disciplines that blend real-world athleticism with advanced gaming technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251024640292/en/ Games of The Future Highlights Community, Innovation and Youth Empowerment (Photo: AETOSWire) Taking place from 18-23 December 2025 at ADNEC Centre Abu Dhabi, the tournament is a natural extension of the ‘We the UAE 2031’ vision and the nation’s designation of 2025 as the Year of Community, reinforcing the UAE's role as a global hub for sport, innovation, youth empowerment, and cultural exchange. His Excellency Dr. Ahmad Belhoul Al Falasi, UAE Minister of Sports, affirmed that Abu Dhabi's hosting of the Games of the Future 2025 is a qualitative new step in the country's journey to consolidat
Thales Named Frost & Sullivan’s 2025 Company of the Year in Automated Border Control24.10.2025 09:00:00 EEST | Press release
As governments and airports face rising passenger volumes, new regulatory requirements such as the European Entry Exit System (EES), and evolving security threats, Thales’s solutions help strike the right balance between strong security and traveller convenience. Frost & Sullivan praised Thales’s end-to-end expertise, customer focus, and ability to design systems that are modular, eco-conscious, and powered by advanced biometrics and artificial intelligence. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251023471400/en/ At the heart of Thales’s innovation is the traveller experience. Crossing a border that once meant long queues and stressful procedures can now be completed in less than 15 seconds. A passenger simply presents their passport, looks briefly at a camera, and passes through an automated gate thanks to biometric verification and real-time checks. This simplicity is supported by advanced technology: Cybersecurity
NTT DOCOMO BUSINESS and NTT Com Asia Launch “APN InterLink” Service in Hong Kong24.10.2025 07:00:00 EEST | Press release
NTT DOCOMO BUSINESS, Inc. (formerly NTT Communications Corporation, hereafter “NTT DOCOMO BUSINESS”) and its Hong Kong subsidiary, NTT Com Asia, today announced the launch of the “APN InterLink” service in Hong Kong for financial institutions starting November 1, 2025, leveraging All-Photonic Network (APN)*1 technology in support of the IOWN®*2 initiative. Commercially deployed in Hong Kong, one of the leading Asia financial hubs, the new service leverages ultra-low latency photonics-based connectivity to address the evolving digital needs of the financial sector, especially for latency-sensitive trading, algorithmic trading*3, proximity market data access and real-time transaction. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251023916941/en/ NTT APN InterLink Service Looking ahead, NTT DOCOMO BUSINESS and NTT Com Asia plan to expand the deployment of IOWN® APN on the Asia Submarine-cable Express (ASE), which connects Tok
Hanshow Wins the Technology Vendor of the Year at 2025 RTIH Innovation Awards in London24.10.2025 06:00:00 EEST | Press release
Hanshow, a global leader in digital retail solutions, has been honoured at the 2025 Retail Technology Innovation Hub (RTIH) Innovation Awards, winning the Technology Vendor of the Year title for its pioneering shelf marketing solution. The recognition underscores Hanshow’s commitment to redefining how retailers and brands engage with shoppers through NFC-enabled ESLs that seamlessly connect physical stores with digital engagement. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251023122859/en/ The RTIH Innovation Awards are widely regarded as one of the most influential recognitions in the global retail technology sector. Each year, the awards celebrate organisations driving innovation, digital transformation, and operational excellence in a fast-moving omnichannel world. The 2025 ceremony, held at The HAC in central London, brought together senior retail executives, technology innovators, and thought leaders shaping the fut
DNIB.com Reports Internet Has 378.5 Million Domain Name Registrations at the End of the Third Quarter of 202524.10.2025 00:00:00 EEST | Press release
VeriSign, Inc. (NASDAQ: VRSN), a global provider of critical internet infrastructure and domain name registry services, today announced that, according to the latest Domain Name Industry Brief Quarterly Report from DNIB.com, the third quarter of 2025 closed with 378.5 million domain name registrations across all top-level domains (TLDs), an increase of 6.8 million domain name registrations, or 1.8% compared to the second quarter of 2025. Domain name registrations also increased by 16.2 million, or 4.5%, year over year. The .com and .net TLDs had a combined total of 171.9 million domain name registrations in the domain name base at the end of third quarter of 2025, an increase of 1.4 million domain name registrations, or 0.8% compared to the second quarter of 2025. The .com and .net TLDs had a combined increase of 2.4 million domain name registrations, or 1.4%, year over year. As of Sept. 30, 2025, the .com domain name base totaled 159.4 million domain name registrations and the .net do
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom